Indivior Pharmaceuticals Inc
(INDV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 253,000 | 241,000 | 232,000 | 221,000 | 207,000 |
| Cost of Goods | 39,000 | 44,000 | 40,000 | 38,000 | 37,000 |
| Gross Profit | 214,000 | 197,000 | 192,000 | 183,000 | 170,000 |
| Operating Expenses | 157,000 | 455,000 | 136,000 | 120,000 | 116,000 |
| Operating Income | 57,000 | -258,000 | 56,000 | 63,000 | 54,000 |
| Interest Expense | 10,000 | 8,000 | 8,000 | 7,000 | 6,000 |
| Other Income | 11,000 | 11,000 | 6,000 | 2,000 | 0 |
| Pre-tax Income | 58,000 | -255,000 | 54,000 | 58,000 | 48,000 |
| Income Tax | 14,000 | -72,000 | 13,000 | 10,000 | 7,000 |
| Net Income Continuous | 44,000 | -183,000 | 41,000 | 48,000 | 41,000 |
| Net Income | $44,000 | $-183,000 | $41,000 | $48,000 | $41,000 |
| EPS Basic Total Ops | 0.32 | -1.30 | 0.29 | 0.34 | 0.29 |
| EPS Basic Continuous Ops | 0.32 | -1.31 | 0.29 | 0.34 | 0.29 |
| EPS Diluted Total Ops | 0.31 | -1.27 | 0.28 | 0.33 | 0.28 |
| EPS Diluted Continuous Ops | 0.31 | -1.27 | 0.28 | 0.33 | 0.28 |
| EBITDA(a) | $63,000 | $-254,000 | $62,000 | $69,000 | $59,000 |